To determine the impact of sarcopenia on erectile functional outcomes after a nerve-sparing (NS) robot-assisted radical prostatectomy (RARP) using patient-reported validated questionnaires.
In this retrospective study, RARP was performed on 841 patients at Okayama University Hospital, of which 132 underwent NS RARP.